Association Between Cytomegalovirus Viremia Clearance and Post-Solid Organ Transplant Mortality in Patients With Refractory Cytomegalovirus Infection: SOLSTICE Post Hoc Analysis

Cytomegalovirus (CMV) infection following solid organ transplant (SOT) is associated with increased mortality risk. In the phase 3 SOLSTICE study (NCT02931539), more transplant recipients achieved CMV clearance after 8 weeks with maribavir than investigator-assigned therapy (IAT). In SOLSTICE, SOT r...

詳細記述

書誌詳細

主要な著者:	Nassim Kamar, Robin K. Avery, Tien Bo, Joan Gu, Deepali Kumar, Oliver Witzke
フォーマット:	Artigo
言語:	Inglês
出版事項:	Frontiers Media S.A. 2025-11-01
シリーズ:	Transplant International
主題:	SOT (solid organ transplant) survival anti-CMV therapy maribavir antiviral
オンライン･アクセス:	https://www.frontierspartnerships.org/articles/10.3389/ti.2025.15331/full
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!